Editors' ChoiceCancer

PARP inhibitors need an extra STING for therapeutic efficacy

See allHide authors and affiliations

Science Translational Medicine  29 May 2019:
Vol. 11, Issue 494, eaax9557
DOI: 10.1126/scitranslmed.aax9557

Article Information

vol. 11 no. 494

Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Anand D. Jeyasekharan
  1. Department of Haematology-Oncology, National University Hospital and Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. Email: csiadj{at}nus.edu.sg

Altmetric

Article usage

Article usage: May 2019 to July 2020

AbstractFullPdf
May 201910920509
Jun 2019131177214
Jul 2019143001
Aug 2019112066
Sep 201962022
Oct 2019221996
Nov 201971982
Dec 2019171540
Jan 202071421
Feb 202091190
Mar 20205870
Apr 202093593
May 202061970
Jun 202031991
Jul 20202626

Stay Connected to Science Translational Medicine

Navigate This Article